These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 19796195)

  • 1. Gadoteridol-induced anaphylaxis - not a class allergy.
    Galera C; Pur Ozygit L; Cavigioli S; Bousquet PJ; Demoly P
    Allergy; 2010 Jan; 65(1):132-4. PubMed ID: 19796195
    [No Abstract]   [Full Text] [Related]  

  • 2. Fatal Anaphylaxis Associated With the Gadolinium-Based Contrast Agent Gadoteridol (ProHance).
    Takahashi S; Takada A; Saito K; Hara M; Yoneyama K; Nakanishi H
    J Investig Allergol Clin Immunol; 2015; 25(5):366-7. PubMed ID: 26727767
    [No Abstract]   [Full Text] [Related]  

  • 3. Nephrogenic systemic fibrosis in Japan: advisability of keeping the administered dose as low as possible.
    Tsushima Y; Takahashi-Taketomi A; Endo K
    Radiology; 2008 Jun; 247(3):915-6. PubMed ID: 18487548
    [No Abstract]   [Full Text] [Related]  

  • 4. Response to the FDA's May 23, 2007, nephrogenic systemic fibrosis update.
    Kanal E; Broome DR; Martin DR; Thomsen HS
    Radiology; 2008 Jan; 246(1):11-4. PubMed ID: 17855656
    [No Abstract]   [Full Text] [Related]  

  • 5. Life-threatening anaphylactoid reaction after intravenous gadoteridol administration in a patient who had previously received gadopentetate dimeglumine.
    Witte RJ; Anzai LL
    AJNR Am J Neuroradiol; 1994 Mar; 15(3):523-4. PubMed ID: 8197951
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Severe anaphylactoid shock secondary to gadolinium contrast media.
    Simons CW; Benouni S; Gibbon G; Klaustermeyer W
    Ann Allergy Asthma Immunol; 2009 Oct; 103(4):359-60. PubMed ID: 19852205
    [No Abstract]   [Full Text] [Related]  

  • 7. Anaphylactic shock induced by gadoterate meglumine (DOTAREM).
    Beaudouin E; Kanny G; Blanloeil Y; Guilloux L; Renaudin JM; Moneret-Vautrin DA
    Eur Ann Allergy Clin Immunol; 2003 Dec; 35(10):382-5. PubMed ID: 14768523
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fatal reaction to gadopentetate dimeglumine.
    Jordan RM; Mintz RD
    AJR Am J Roentgenol; 1995 Mar; 164(3):743-4. PubMed ID: 7863905
    [No Abstract]   [Full Text] [Related]  

  • 9. Incidence of immediate gadolinium contrast media reactions.
    Prince MR; Zhang H; Zou Z; Staron RB; Brill PW
    AJR Am J Roentgenol; 2011 Feb; 196(2):W138-43. PubMed ID: 21257854
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The Grenelle of MR contrast agents?].
    Clément O
    J Radiol; 2007 Nov; 88(11 Pt 1):1663. PubMed ID: 18065924
    [No Abstract]   [Full Text] [Related]  

  • 11. [Anaphylactoid reaction caused by intravenous gadopentetate dimeglumine in magnetic resonance].
    Campos A; Aznar L; Alamar R; Castelló JV
    Med Clin (Barc); 1996 Feb; 106(5):197. PubMed ID: 8684023
    [No Abstract]   [Full Text] [Related]  

  • 12. Anaphylactic shock induced by intravenous gadopentetate dimeglumine.
    Tardy B; Guy C; Barral G; Page Y; Ollagnier M; Bertrand JC
    Lancet; 1992 Feb; 339(8791):494. PubMed ID: 1346846
    [No Abstract]   [Full Text] [Related]  

  • 13. Anaphylaxis to trometamol excipient in gadolinium-based contrast agents for clinical imaging.
    Lukawska J; Mandaliya D; Chan AWE; Foggitt A; Bidder T; Harvey J; Stycharczuk L; Bisdas S
    J Allergy Clin Immunol Pract; 2019 Mar; 7(3):1086-1087. PubMed ID: 30217530
    [No Abstract]   [Full Text] [Related]  

  • 14. Adverse reaction to intravenous gadoteridol.
    Shellock FG; Hahn HP; Mink JH; Itskovich E
    Radiology; 1993 Oct; 189(1):151-2. PubMed ID: 8372186
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anaphylactic shock after first exposure to a macrocyclic gadolinium chelate: a few comments.
    Idée JM; Corot C
    J Allergy Clin Immunol; 2008 Jul; 122(1):215-6; author reply 216-7. PubMed ID: 18547628
    [No Abstract]   [Full Text] [Related]  

  • 16. [Nephrotoxicity of contrast media in magnetic resonance tomography (MRI)].
    Heuck A; Reiser M
    Internist (Berl); 1997 Dec; 38(12):1234-5. PubMed ID: 9465330
    [No Abstract]   [Full Text] [Related]  

  • 17. Life-threatening anaphylactoid reaction after iv injection of gadoterate meglumine.
    Meuli RA; Maeder P
    AJR Am J Roentgenol; 1996 Mar; 166(3):729. PubMed ID: 8623674
    [No Abstract]   [Full Text] [Related]  

  • 18. Prospective Cohort Study of Nephrogenic Systemic Fibrosis in Patients With Stage 3-5 Chronic Kidney Disease Undergoing MRI With Injected Gadobenate Dimeglumine or Gadoteridol.
    Soulez G; Bloomgarden DC; Rofsky NM; Smith MP; Abujudeh HH; Morgan DE; Lichtenstein RJ; Schiebler ML; Wippold FJ; Russo C; Kuhn MJ; Mennitt KW; Maki JH; Stolpen A; Liou J; Semelka RC; Kirchin MA; Shen N; Pirovano G; Spinazzi A
    AJR Am J Roentgenol; 2015 Sep; 205(3):469-78. PubMed ID: 26295633
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fatal anaphylaxis caused by gadolinium due to beta-tryptase-induced hemorragic diathesis.
    Prieto-García A; Pérez-David E; Devesa C; Tornero P; Schwartz LB; Pascual C; Castells MC
    J Allergy Clin Immunol Pract; 2017; 5(5):1433-1434. PubMed ID: 28634099
    [No Abstract]   [Full Text] [Related]  

  • 20. Anaphylactoid reactions to i.v. gadopentetate dimeglumine.
    Tishler S; Hoffman JC
    AJNR Am J Neuroradiol; 1990; 11(6):1167; discussion 1168-9. PubMed ID: 2124049
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.